Lobular carcinoma in situ (LCIS) Treatment in Hyderabad

overview

Lobular carcinoma in situ
Lobular carcinoma in situ Open the popup dialog
Lobular carcinoma in situ (LCIS) is a rare disease in which abnormal cells form in the mammary glands (lobules) of the breast. LCIS ​​is not a cancer. However, a diagnosis of LCIS suggests that you are at increased risk of developing breast cancer.

LCIS ​​does not usually appear on mammograms. The disease most often occurs after a breast biopsy done for another reason, such as: Due to suspicious breast mass or abnormal mammography. Lobular carcinoma in situ (LCIS) Treatment in Hyderabad

Women with LCIS are at increased risk of developing invasive breast cancer of both breasts. If you are diagnosed with LCIS, your doctor may recommend increased breast cancer screening and may ask you to consider medical treatments to reduce your risk of developing invasive breast cancer.

symptoms

LCIS ​​does not cause any signs or symptoms. On the contrary, your doctor may discover that you have LCIS by chance – for example, after a biopsy to look for a breast lump or an abnormal area on a mammogram.

The reasons

If LCIS is found during a breast biopsy, it does not mean you have cancer. However, LCIS increases the risk of breast cancer and the risk of developing invasive breast cancer.

The risk of breast cancer in women diagnosed with LCIS is estimated to be around 20 percent. In other words, out of 100 women diagnosed with LCIS, 20 will be diagnosed with breast cancer and 80 will not be diagnosed with breast cancer. The risk of developing breast cancer in women is generally believed to be 12%. In other words, out of 100 women in the general population, 12 women will be diagnosed with breast cancer. Lobular carcinoma in situ (LCIS) Treatment in Hyderabad

Leave a Reply

Your email address will not be published.